Magle Chemoswed Holding AB (publ) (MAGLE.ST)
SEK 33.2
(1.84%)
SEK 33.2
(1.84%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 35.22 Million SEK | 20.91% |
| 2022 | 29.13 Million SEK | 66.56% |
| 2021 | 17.49 Million SEK | -4.65% |
| 2020 | 18.34 Million SEK | -32.65% |
| 2019 | 27.24 Million SEK | -18.96% |
| 2018 | 33.61 Million SEK | -10.26% |
| 2017 | 37.46 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 33.12 Million SEK | -5.96% |
| 2024 Q3 | 101.78 Million SEK | 139.97% |
| 2024 Q2 | 42.41 Million SEK | 28.04% |
| 2023 Q3 | 34.77 Million SEK | -0.05% |
| 2023 Q4 | 35.22 Million SEK | 1.32% |
| 2023 Q1 | 31.86 Million SEK | 9.38% |
| 2023 Q2 | 34.78 Million SEK | 9.16% |
| 2023 FY | 35.22 Million SEK | 20.91% |
| 2022 Q3 | 31.4 Million SEK | 1.38% |
| 2022 Q2 | 30.98 Million SEK | 25.19% |
| 2022 Q1 | 24.74 Million SEK | 41.47% |
| 2022 FY | 29.13 Million SEK | 66.56% |
| 2022 Q4 | 29.13 Million SEK | -7.24% |
| 2021 Q1 | 18.09 Million SEK | -1.38% |
| 2021 FY | 17.49 Million SEK | -4.65% |
| 2021 Q4 | 17.49 Million SEK | -13.73% |
| 2021 Q3 | 20.27 Million SEK | 10.42% |
| 2021 Q2 | 18.36 Million SEK | 1.5% |
| 2020 FY | 18.34 Million SEK | -32.65% |
| 2020 Q3 | 18.63 Million SEK | 4.93% |
| 2020 Q2 | 17.75 Million SEK | 5.86% |
| 2020 Q1 | 16.77 Million SEK | -38.43% |
| 2020 Q4 | 18.34 Million SEK | -1.53% |
| 2019 Q4 | 27.24 Million SEK | 0.0% |
| 2019 FY | 27.24 Million SEK | -18.96% |
| 2019 Q1 | - SEK | 0.0% |
| 2018 FY | 33.61 Million SEK | -10.26% |
| 2017 FY | 37.46 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alligator Bioscience AB (publ) | 2.00 SEK | -1761449900.0% |
| Ziccum AB (publ) | -4.18 Million SEK | 940.988% |
| Modus Therapeutics Holding AB (publ) | - SEK | -Infinity% |
| BioArctic AB (publ) | - SEK | -Infinity% |
| Sprint Bioscience AB (publ) | -7.13 Million SEK | 593.68% |
| Mendus AB (publ) | - SEK | -Infinity% |
| Genovis AB (publ.) | 14.9 Million SEK | -136.357% |
| Intervacc AB (publ) | 10.48 Million SEK | -236.058% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | - SEK | -Infinity% |
| Active Biotech AB (publ) | -2500.00 SEK | 1409260.0% |
| Bio-Works Technologies AB (publ) | 9.06 Million SEK | -288.498% |
| Aptahem AB (publ) | - SEK | -Infinity% |
| Vicore Pharma Holding AB (publ) | - SEK | -Infinity% |
| Kancera AB (publ) | -1950.00 SEK | 1806715.385% |
| Infant Bacterial Therapeutics AB (publ) | - SEK | -Infinity% |
| Fluicell AB (publ) | 3.15 Million SEK | -1018.381% |
| Saniona AB (publ) | 1.00 SEK | -3522899900.0% |
| Lipigon Pharmaceuticals AB (publ) | -1.62 Million SEK | 2266.605% |
| Biovica International AB (publ) | 2.19 Million SEK | -1502.046% |
| Spago Nanomedical AB (publ) | 1.00 SEK | -3522899900.0% |
| AcouSort AB (publ) | 2.08 Million SEK | -1593.702% |
| Xintela AB (publ) | 398 Thousand SEK | -8751.508% |
| Abliva AB (publ) | - SEK | -Infinity% |
| Egetis Therapeutics AB (publ) | 700 Thousand SEK | -4932.714% |
| Karolinska Development AB (publ) | - SEK | -Infinity% |
| OncoZenge AB (publ) | -862.99 Thousand SEK | 4182.16% |
| Amniotics AB (publ) | 534 Thousand SEK | -6497.191% |
| 2cureX AB (publ) | -1000.00 SEK | 3523000.0% |
| CombiGene AB (publ) | -1.79 Million SEK | 2058.255% |
| Asarina Pharma AB (publ) | - SEK | -Infinity% |
| Calliditas Therapeutics AB (publ) | 20.42 Million SEK | -72.454% |
| Camurus AB (publ) | 100.95 Million SEK | 65.104% |
| Corline Biomedical AB | -3.85 Million SEK | 1013.378% |
| IRLAB Therapeutics AB (publ) | 1000.00 SEK | -3522800.0% |
| Isofol Medical AB (publ) | - SEK | -Infinity% |
| I-Tech AB | 4.28 Million SEK | -723.107% |
| Hansa Biopharma AB (publ) | 9.79 Million SEK | -259.773% |
| Cyxone AB (publ) | - SEK | -Infinity% |
| ExpreS2ion Biotech Holding AB (publ) | - SEK | -Infinity% |
| Biosergen AB | -4.92 Million SEK | 814.729% |
| Cantargia AB (publ) | - SEK | -Infinity% |
| NextCell Pharma AB | 545.23 Thousand SEK | -6361.227% |
| Xspray Pharma AB (publ) | 43.78 Million SEK | 19.534% |
| Elicera Therapeutics AB (publ) | -446.98 Thousand SEK | 7981.455% |
| Nanologica AB (publ) | 2.97 Million SEK | -1084.965% |
| SynAct Pharma AB | - SEK | -Infinity% |
| Annexin Pharmaceuticals AB (publ) | - SEK | -Infinity% |
| Stayble Therapeutics AB (publ) | -321.14 Thousand SEK | 11069.811% |
| LIDDS AB (publ) | - SEK | -Infinity% |
| Lipum AB (publ) | - SEK | -Infinity% |
| BioInvent International AB (publ) | 11.84 Million SEK | -197.442% |
| Alzinova AB (publ) | -3.27 Million SEK | 1174.711% |
| Oncopeptides AB (publ) | 2.42 Million SEK | -1352.742% |
| Pila Pharma AB (publ) | 1.00 SEK | -3522899900.0% |
| Guard Therapeutics International AB (publ) | -1486.00 SEK | 2370826.783% |
| Scandinavian ChemoTech AB (publ) | 4.03 Million SEK | -773.302% |
| Simris Alg AB (publ) | 1.09 Million SEK | -3129.056% |
| Diamyd Medical AB (publ) | 24.05 Million SEK | -46.482% |
| Xbrane Biopharma AB (publ) | 106.85 Million SEK | 67.031% |
| Ascelia Pharma AB (publ) | - SEK | -Infinity% |
| Diagonal Bio AB (publ) | 1.02 Million SEK | -3326.946% |